REGULUS THERAPEUTICS INC (RGLS)
US75915K3095 - Common Stock
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -41.63M | -30.04M | -28.32M | -27.81M | -15.73M | |||
| Depreciation Amortization | 336.00K | 227.00K | 120.00K | 460.00K | 470.00K | |||
| Change In Working Capital | 183.00K | 257.00K | 550.00K | 910.00K | -40.00K | |||
| Interest Paid | 134.00K | 447.00K | 490.00K | 730.00K | 1.36M | |||
| Taxes Paid | N/A | 1.00K | 0.00 | 0.00 | 0.00 | |||
| Other non cash items | 5.16M | 2.79M | 2.13M | 2.31M | 2.77M | |||
| OPERATING CASH FLOW | -35.95M | -26.77M | -25.53M | -24.13M | -12.54M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -411.00K | -613.00K | -360.00K | -250.00K | 0.00 | |||
| Other Investing Activity | -54.64M | 15.10M | -14.76M | 0.00 | -10.00K | |||
| INVESTING CASH FLOW | -55.05M | 14.49M | -15.12M | -250.00K | -10.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -2.20M | -3.30M | 0.00 | -80.00K | -9.62M | |||
| Stock Issued/Repurchased | 93.75M | 15.12M | 4.49M | 21.46M | 960.00K | |||
| Other Financing Activity | N/A | N/A | 0.00 | 32.36M | 18.17M | |||
| FINANCING CASH FLOW | 91.54M | 11.82M | 4.49M | 53.74M | 9.51M | |||
| CHANGE IN CASH | 540.00K | -461.00K | -36.16M | 29.36M | -3.04M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -35.95M | -26.77M | -25.53M | -24.13M | -12.54M | |||
| Capital Expenditure | -411.00K | -613.00K | -360.00K | -250.00K | 0.00 | |||
| FREE CASH FLOW | -36.36M | -27.38M | -25.89M | -24.38M | -12.54M | |||
All data in USD